LUNESTA
LUNESTA
Approved
DIN Number
02453215
Drug Class
Human
Market Date
Oct 20, 2020
Company
HC
sumitomo pharma canada, inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02453215
AIG Number0157971002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N05CF04 ESZOPICLONE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:24.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
ESZOPICLONEActive
Strength: 2 MG
Monograph: ESZOPICLONE